dc.contributor.author | Andrikopoulos, P | en_US |
dc.contributor.author | Kieswich, J | en_US |
dc.contributor.author | Pacheco, S | en_US |
dc.contributor.author | Nadarajah, L | en_US |
dc.contributor.author | Harwood, SM | en_US |
dc.contributor.author | O'Riordan, CE | en_US |
dc.contributor.author | Thiemermann, C | en_US |
dc.contributor.author | Yaqoob, MM | en_US |
dc.date.accessioned | 2019-01-15T17:09:28Z | |
dc.date.available | 2018-10-13 | en_US |
dc.date.issued | 2019-01 | en_US |
dc.identifier.issn | 1046-6673 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/54661 | |
dc.format.extent | 33 - 49 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | en_US |
dc.title | The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling | en_US |
dc.type | Article | |
dc.rights.holder | American Society of Nephrology | |
dc.identifier.doi | 10.1681/ASN.2018020209 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000454766200007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 1 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 30 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |